15 results
8-K
EX-99.1
VXRT
Vaxart Inc
1 Sep 22
Regulation FD Disclosure
7:05am
and future variants by harnessing multiple immune system mechanisms. I believe this is what transformative innovation looks like. We will continue
8-K
EX-99.1
VXRT
Vaxart Inc
28 Jun 22
Other Events
5:09pm
. And that success is important because Vaxart is working on transformative innovation, which has the potential to make a significant impact on people's … very real. So I think lots of people now understand that we clearly need transformational innovation here. We just need better next-generation vaccines
8-K
7z77pvi8ps7bf
11 May 22
Departure of Directors or Certain Officers
5:27pm
8-K
EX-99.1
azlngqi7
9 Jul 21
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
4:02pm
8-K
7htu0ojre
18 Jun 20
Regulation FD Disclosure
1:26pm
8-K
EX-99.2
8z6wco6k1gf2lerd
19 Mar 20
Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results
4:04pm
DEFM14A
udqb25bbuqy3 ng8u
7 Aug 12
Proxy related to merger
12:00am
- Prev
- 1
- Next